EUVIMEDEUVIMED entdecken
Historischer BeitragOpen Access

Vaccine and Treatment Evaluation Units: A Historical Perspective

Robert B Belshe iD, David I Bernstein iD, Kathryn M Edwards iD, Sharon E Frey iD, Wendy A Keitel iD, Myron M Levine, John J Treanor, Peter F Wright

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf454 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Robert B Belshe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Development, Saint Louis University, Saint Louis, Missouri, USA. Hauptthemen laut MEDLINE: Vaccine Development, Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

On 27 February 1962, Surgeon General Luther Terry announced a new vaccine development program within the National Institute of Allergy and Infectious Diseases (NIAID). Initially, the plan had three components: (1) special laboratories and facilities for development of prototype vaccines; (2) pilot lot production facilities and preliminary vaccine trial sites; and (3) larger lot production capacity and expanded human testing. Respiratory viruses were targeted as the top priority for vaccine development. Over 5 decades, this program has evolved and expanded to include multiple academic vaccine evaluation sites within the network, now labeled as the Vaccine and Treatment Evaluation Units (VTEUs). The network has evaluated many different vaccines, with many shown to be safe, effective, and licensed for recommended use. This manuscript offers a historical perspective, crafted by early investigators from currently funded VTEUs, to showcase how some of the original VTEUs—both individually and collectively—advanced vaccine science and shaped the strategies and achievements that continue to impact public health today.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccine DevelopmentVaccinesHumansHistory, 20th CenturyHistory, 21st CenturyUnited StatesNational Institute of Allergy and Infectious Diseases (U.S.)

Substanzen

Vaccines

Autor:innen und Institutionen

  • Center for Vaccine Development, Saint Louis University, Saint Louis, Missouri, USA.
  • Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.
  • Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vanderbilt Vaccine Research Program.
  • Molecular Virology & Microbiology and Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Robert B Belshe, David I Bernstein, Kathryn M Edwards, Sharon E Frey, Wendy A Keitel

Förderung

  • NIAID NIH HHS

Zitieren

APA

Belshe, R. B., Bernstein, D. I., Edwards, K. M., Frey, S. E., Keitel, W. A., Levine, M. M., Treanor, J. J., & Wright, P. F. (2025). Vaccine and Treatment Evaluation Units: A Historical Perspective. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf454

Vancouver

Belshe RB, Bernstein DI, Edwards KM, Frey SE, Keitel WA, Levine MM, et al. Vaccine and Treatment Evaluation Units: A Historical Perspective. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf454

BibTeX
@article{Belshe2025,
  author = {Belshe, Robert B and Bernstein, David I and Edwards, Kathryn M and Frey, Sharon E and Keitel, Wendy A and Levine, Myron M and Treanor, John J and Wright, Peter F},
  title = {Vaccine and Treatment Evaluation Units: A Historical Perspective},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf454}
}
Kostenlos starten →